CAC
CRNC icon

Cowen and Company’s Cerence CRNC Stock Holding History

Cowen and Company’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$1K – 691
2022
Q3 		$1K Buy
+10,000
New +$225K ﹤0.01% 616

Other funds holding CRNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cowen and Company's CRNC Position: Q4 2022 in Review

Cowen and Company sold out of Cerence (CRNC) in Q4 2022, closing a stake of 10,000 shares — an estimated $1K sold.

Cowen and Company first reported a position in CRNC in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 223 funds tracked by Wall St. Rank hold CRNC as of Q4 2022.

  • Cowen and Company reported no remaining Cerence position as of Q4 2022 after selling out during the quarter.
  • Cowen and Company sold 10,000 Cerence shares in Q4 2022, an estimated $1K.
  • Cowen and Company first reported a position in Cerence in Q3 2022 and held it in 1 quarter.
  • Cowen and Company's Cerence position peaked at $1K in Q3 2022.
  • 223 funds tracked by Wall St. Rank held Cerence as of Q4 2022.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.